Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.58 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 5/20 | 0.45 |
| ▸ | THRA | P10827 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | HTR2B | P41595 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182212 | 1.00 | GABRA1 (0.58) | GABRA1GABRB1ALOX15GABRB2HPGD | |
| Formaldehyde SCHEMBL27866505 | 0.94 | GABRA1 (0.52) | GABRA1GABRB1ALOX15GABRB2HPGD | |
| SCHEMBL23037481 | 0.89 | GABRA1 (0.47) | GABRA1GABRB1ALOX15GABRB2HPGD | |
| SCHEMBL6529715 | 0.86 | GABRA1 (0.44) | GABRA1GABRB1ALOX15GABRB2HPGD | |
| SCHEMBL2984801 | 0.84 | ALOX15 (0.48) | GABRA1GABRB1ALOX15GABRB2HPGD | |
| SCHEMBL20855720 | 0.83 | ALOX15 (0.46) | GABRA1GABRB1ALOX15HPGDLMNA | |
| SCHEMBL20855723 | 0.83 | ALOX15 (0.46) | GABRA1GABRB1ALOX15HPGDLMNA | |
| SCHEMBL6273718 | 0.83 | ALOX15 (0.46) | GABRA1GABRB1ALOX15GABRB2HPGD | |
| SCHEMBL4912678 | 0.82 | LMNA (0.59) | GABRA1GABRB1ALOX15GABRB2HPGD | |
| SCHEMBL3083574 | 0.81 | ALOX15 (0.45) | GABRA1GABRB1ALOX15HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037020-A | Supported catalyst, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-119613233-A | Eutectic compound, preparation method and application thereof | 上海科胜药物研发有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-112423756-B | New process for the synthesis of phenoxy diaminopyrimidine compounds | 默沙东有限责任公司 | 2024-08-13 | — | — | CN | claimed |
| CN-115894554-A | Preparation method of phosphonic acid compound | 烟台药物研究所 | 2023-04-04 | — | — | CN | claimed |
| US-11584724-B2 | Process for synthesis of a phenoxy diaminopyrimidine compound | MERCK SHARP & DOHME LLC (US) | 2023-02-21 | — | — | US | claimed |
| US-20210122717-A1 | NOVEL PROCESS FOR SYNTHESIS OF A PHENOXY DIAMINOPYRIMIDINE COMPOUND | MERCK SHARP & DOHME CORP. (US) | 2021-04-29 | — | — | US | claimed |
| EP-3784242-A1 | NOVEL PROCESS FOR SYNTHESIS OF A PHENOXY DIAMINOPYRIMIDINE COMPOUND | Merck Sharp&Dohme Corp. (US) | 2021-03-03 | — | — | EP | claimed |
| CN-112423756-A | Novel process for the synthesis of phenoxydiaminopyrimidine compounds | 默沙东公司 | 2021-02-26 | — | — | CN | claimed |
| JP-6001746-A | — | — | None | — | — | JP | disclosed |
| CN-122037020-A | Supported catalyst, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12304907-B2 | Compounds and methods of use | TANGO THERAPEUTICS, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| US-12264154-B2 | Compounds and methods of use | TANGO THERAPEUTICS, INC. (US) | 2025-04-01 | — | — | US | disclosed |
| CN-119613233-A | Eutectic compound, preparation method and application thereof | 上海科胜药物研发有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-5530015-A | Dihaloprene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-06-25 | — | — | US | disclosed |
| CN-1108642-A | Dihalopropene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient and intermediate compound for use inproduct of said dihalopropene compounds | SUMITOMO CHEMICAL CO (JP) | 1995-09-20 | — | — | CN | disclosed |
| EP-0648729-A1 | Dihalopropene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient and intermediate compound for use in production of said dihalopropene compound | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1995-04-19 | — | — | EP | disclosed |
| JP-H061746-A | PRODUCTION OF PHENANTHRENE DERIVATIVE AND DIOXOPHENANTHRENE DERIVATIVE | OTSUKA PHARMACEUT FACTORY INC | 1994-01-11 | — | — | JP | disclosed |
| US-4943666-A | Process for producing nitrophenol compound | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-07-24 | — | — | US | disclosed |
| EP-0339956-A1 | Process for producing nitrophenol compound | Takeda Chemical Industries, Ltd. (JP) | 1989-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584724-B2 | Process for synthesis of a phenoxy diaminopyrimidine compound | DPYD, DCTPP1, CTDSP1 | GABRA1 3237/4885GABRB1 3348/4885ALOX15 4614/4885 |
| US-20210122717-A1 | NOVEL PROCESS FOR SYNTHESIS OF A PHENOXY DIAMINOPYRIMIDINE COMPOUND | DCTPP1, DPYD, CTDSP1 | GABRA1 3146/4885GABRB1 3147/4885ALOX15 4764/4885 |
| US-12264154-B2 | Compounds and methods of use | F12, C1R, ABCG2 | GABRA1 1744/4885GABRB1 1936/4885ALOX15 2070/4885 |
| US-12304907-B2 | Compounds and methods of use | F12, C1R, ABCG2 | GABRA1 1744/4885GABRB1 1936/4885ALOX15 2070/4885 |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | NR3C2, ADRA1A, CNR1 | GABRA1 581/4885GABRB1 727/4885ALOX15 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.